CClinicalTrials.gg
Status unknownNCT02119078Updated Nov 4, 2019

Acute Care for Elders (ACE) Program at OHSU Hospital

An interventional study of Acute Care of Elders focused geriatric care in Delirium, Age-Related Cognitive Decline and Frail Elderly, sponsored by Oregon Health and Science University. Status unknown at 1 site in United States. Per ClinicalTrials.gov, last updated 2019-11-04.

Sponsored by Oregon Health and Science University · Not applicable, Interventional, and Health services research

The sponsor has not verified this record recently (last verified Oct 2019), so the status shown — last known as Active, not recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
300
Allocation
Non-randomized
Sex
All
01

Study summary

The purpose of this investigation is to assess the effectiveness of a multi-disciplinary Acute Care for Elders (ACE) program dedicated to the care of patients age 70 and older admitted to Oregon Health \& Science University's hospital medicine service. The ACE program will aim to improve the quality of care of older patients in the investigators hospital by implementing focused interventions and recommendations specific to geriatric needs and syndromes, including: reduced fall rate, decreased incidence and duration of delirium, early recognition and treatment of impaired mobility and function, careful minimization of medication use, prevention of unnecessary catheter and restraint use, decreased hospital readmission rates, improved transitional care following hospital discharge, and high levels of patient and referring physician satisfaction. Additionally, the ACE program aims to improve resident and student competence in treating geriatric syndromes, and to improve staff and learner satisfaction with caring for older adults. ACE programs have been well studied at other institutions, so the investigators will be implementing a program that is already standard of care, and studying the elements that are unique to OHSU.

This will be a quality improvement project. Study participants will be a convenience sample of OHSU faculty, staff, residents and students who are employed by or on rotation with General Medicine Team 1 of the Medicine Teaching Service. Faculty, staff, and learners (ACE team members) will receive the ACE training. Study personnel will conduct prospective and retrospective chart review of patients admitted to the ACE service to determine outcomes as noted above.

02

Conditions studied

  • Delirium
  • Age-Related Cognitive Decline
  • Frail Elderly
  • Hospital Acquired Pressure Ulcer
  • Drug-Related Side Effects and Adverse Reactions

Keywords

  • Geriatrics
  • Acute Care for Elders
  • Geriatric syndromes
  • Delirium
  • Falls
  • Polypharmacy
03

In context

Delirium

1,057 studies on the registry are indexed under Delirium; 238 are open to participants now.

This study's planned enrollment of 300 is above the median of 120 across 599 interventional studies indexed under Delirium.

Browse Delirium studies →

Lead sponsor

Oregon Health and Science University is the lead sponsor of 676 studies on the registry; 136 are open to participants now.

Of its 49 completed or terminated interventional studies of FDA-regulated products, 36 (73%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion Criteria (ACE faculty, health care providers and students):

  • employed by OHSU or enrolled in one of OHSU's schools (medicine, nursing, pharmacy)
  • share in the care of older adults on the General Medicine Team 1 service.

Inclusion criteria

Inclusion Criteria (patients):

  • admitted to the internal medicine service during the time frame of the study
  • age 70 or older at time of hospital admission

Exclusion Criteria (ACE faculty, health care providers and students):

  • non-English-speaking

Exclusion criteria

Exclusion Criteria (patients):

  • none
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
300 participants (estimated)

Study arms

  • Active comparator
    ACE Service

    Admission to the Acute Care for Elders (General Medicine Team 1) service. (See Intervention, below)

    Other: Acute Care of Elders focused geriatric care

  • No intervention
    Standard care (other General Medicine teams)

    Admission to one of the 4 non-ACE general medicine teaching teams at OHSU.

Interventions

  • OtherAcute Care of Elders focused geriatric care

    Patients admitted to the ACE Service will receive standard care as well as additional use of geriatric-specific order sets and protocols and oversight of care by a geriatric-trained Advanced Practice Provider (APP).

06

What researchers measure

Primary outcomes

  1. Number of geriatric patients with adverse events

    Incidence and duration of delirium (source: hospital problem list); incidence of hospital-acquired pressure ulcers (source: nursing documentation, problem list); number of prescriptions for Beers List medications during hospitalization and upon discharge (source: MAR)

    Time frame: During hospitalization, an expected average of 6 days

Secondary outcomes

  1. Resident confidence in treating geriatric syndromes

    As measured by the Post-ACE Survey resident questionnaire, which includes 17 metrics of confidence (e.g. management of pain, identification of fall risk factors, delivering bad news, discussion of hospice care, performing a complete skin exam, documenting advanced directives, managing insomnia, performing bedside cognitive assessments.)

    Time frame: After 3 week rotation on the Acute Care for Elders service

07

Study locations

1 site
  • Oregon Health & Science University Hospital
    Portland, Oregon 97239, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 4, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02119078
Lead sponsor
Oregon Health and Science University
Responsible party
Juliana Bernstein (Assistant Professor, Physician Assistant, Oregon Health and Science University) — Principal investigator
First posted
Apr 21, 2014
Start date
Jan 2014
Primary completion
Jun 30, 2017
Completion
Dec 20, 2020 (estimated)
Last update
Nov 4, 2019

Study contacts

Juliana M Bernstein, MPAS, PA-C
principal investigator · Oregon Health and Science University

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Oct 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion